2CD-2,5-DiEtO
Pharmaceutical compound
From Wikipedia, the free encyclopedia
2CD-2,5-DiEtO, also known as 2,5-diethoxy-4-methylphenethylamine, is a psychoactive drug of the phenethylamine, 2C, and TWEETIO families related to the psychedelic drug 2C-D.[1][2][3] It is the derivative of 2C-D in which the methoxy groups at the 2 and 5 positions have been replaced with ethoxy groups.[1][2][3]
- None
| Clinical data | |
|---|---|
| Other names | 2CD-DiEtO; 2CD-Di-EtO; 2CD-DIETO; 2CD-DI-ETO; 2,5-Diethoxy-4-methylphenethylamine; 4-Methyl-2,5-diethoxyphenethylamine |
| Routes of administration | Oral[1][2][3] |
| Drug class | Psychoactive drug |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 4 hours[1][2][3] |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C13H21NO2 |
| Molar mass | 223.316 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
According to Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, 2CD-2,5-DiEtO's dose is greater than 55 mg orally and its duration is 4 hours.[1][2][3] 2CD-2,5-DiEtO has been described as producing mild effects that were no greater than a "plus-one" on the Shulgin Rating Scale.[1][2][3] No specific effects have been described and higher doses were not tested.[1][2][3]
The chemical synthesis of 2CD-2,5-DiEtO has been described.[1]
2CD-2,5-DiEtO was first described in the literature by Shulgin in PiHKAL in 1991.[1] It was developed and tested by Darrell Lemaire, with publication via personal communication with Shulgin.[2][4][5][6][7] The drug is a controlled substance in Canada under phenethylamine blanket-ban language.[8]